Sasha E. Larsen

Medicine · Health Sciences

23h-index1.8kcitations57works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(24), Mycobacterium research and diagnosis(16), SARS-CoV-2 and COVID-19 Research(12), Immune Cell Function and Interaction(10), Immunotherapy and Immune Responses(8)

Publications56 total

Activity of a Three-Phage Combination against Mycobacterium Tuberculosis in Disease-Relevant Conditions
SSRN Electronic Journal·2026Open Access
Safety and immunogenicity of the Sm-p80 GLA-SE schistosomiasis vaccine
npj Vaccines·2025· 1 citedOpen Access
Safety and immunogenicity of intranasal parainfluenza virus type 5 (PIV5)–vectored COVID-19 vaccine in adults and teens in an open-label phase 1 trial
Science Advances·2025· 3 citedOpen Access
Intradermal Inoculation of <em>Mycobacterium avium</em> in the Mouse Ear
Journal of Visualized Experiments·2025Open Access
Infant Antibodies After Maternal COVID-19 Vaccination During Pregnancy or Postpartum
PEDIATRICS·2025· 2 citedOpen Access
Preclinical Evidence for Phage Therapy to Treat Mycobacterial Infections: A Narrative Review
PHAGE·2025· 1 citedOpen Access
Development and Concordance of Binding and Neutralizing Assays to Determine SARS-CoV-2 Antibody Activity in Human Milk
Pathogens and Immunity·2025Open Access
Comparative study on the virulence of mycobacteriophages
Journal of Virology·2025Open Access
Characterizing TLR4 agonist EmT4™ as an anti-<i>Mycobacterium tuberculosis</i> vaccine adjuvant
ImmunoHorizons·2025· 1 citedOpen Access
Evaluation of host immune responses to Mycobacteriophage Fionnbharth by route of delivery
Virology Journal·2025· 4 citedOpen Access
Assessment of tuberculosis drug efficacy using preclinical animal models and in vitro predictive techniques
npj Antimicrobials and Resistance·2024· 2 citedOpen Access
Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals
Frontiers in Immunology·2024· 21 citedOpen Access
Backtranslation of human RNA biosignatures of tuberculosis disease risk into the preclinical pipeline is condition dependent
mSphere·2024· 1 citedOpen Access
The chosen few: Mycobacterium tuberculosis isolates for IMPAc-TB
UNC Libraries·2024Open Access
The chosen few: Mycobacterium tuberculosis isolates for IMPAc-TB
Frontiers in Immunology·2024· 4 citedOpen Access
Comparative study on the virulence of mycobacteriophages
2024Open Access
Mucosal BCG delivery provides a spectrum of protection from different Mycobacterium tuberculosis strains across susceptible and resistant mouse backgrounds
Frontiers in Tuberculosis·2024Open Access
Backtranslation of human RNA biosignatures of tuberculosis disease risk into the preclinical pipeline is condition dependent
2024Open Access
Protective interplay: Mycobacterium tuberculosis diminishes SARS-CoV-2 severity through innate immune priming
Frontiers in Immunology·2024· 4 citedOpen Access
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
npj Vaccines·2023· 29 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Rhea N. Coler(37), Susan L. Baldwin(24), Tiffany Pecor(16), Valerie A. Reese(12), Andrew L. Snow(10), Bryan J. Berube(9), Hazem F. M. Abdelaal(7), Brendan K. Podell(6), Kathleen M. Neuzil(4), Mehul S. Suthar(4), Steven G. Reed(4), Graham F. Hatfull(4), Brittany D. Williams(4), Steven G. Reed(4), Brian Granger(4), Debora Ferede(4), Suhavi Kaur(4), Matthew H. Harband(4), Carlos A. Guerrero-Bustamante(4), Christine M. Posavad(3)